Trials / Unknown

UnknownNCT03741205

Impact of SPEAC® System Data on Therapeutic Decisions Related to Convulsive Seizure Patients With a Recent Non-diagnostic EMU Visit

Status: Unknown
Phase: N/A
Study type: Interventional
Enrollment: 40 (estimated)

Sponsor: Brain Sentinel · Academic / Other
Sex: All
Age: 22 Years
Healthy volunteers: Not accepted

Summary

This is an open label, randomized, prospective study of the impact on healthcare utilization of a surface Electromyography (sEMG) based seizure monitoring and alerting system for Veterans with seizures with upper extremity motor involvement, who have had a recent non-diagnostic EMU stay.

Conditions

Epilepsy

Interventions

Type	Name	Description
DEVICE	SPEAC System	Surface Electromyography (sEMG) based seizure monitoring and alerting system

Timeline

Start date: 2020-07-01
Primary completion: 2021-01-01
Completion: 2026-01-01
First posted: 2018-11-14
Last updated: 2020-02-07

Regulatory

FDA-regulated device study

Source: ClinicalTrials.gov record NCT03741205. Inclusion in this directory is not an endorsement.